$HE

S&P upgrades Hawaiian Electric rating on wildfire mitigation By Investing.com

S&P Global Ratings upgraded Hawaiian Electric Industries and subsidiaries to BB- from B+ with a stable outlook, citing declining wildfire risk. The Hawaii Public Utilities Commission approved about $350 million cost recovery for wildfire mitigation over three years. S&P expects funds from operations to debt near 10.5% in 2026, improving above 12% in 2027, and affirmed related debt ratings.

Original reporting
Published Jul 22, 2026, 6:36 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 22, 2026, 6:49 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefRegulation
Primary signal
$HE
Bullish
medium confidence
Mentioned
$HE
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$HEBullishMed
01

Why it matters

The upgrade is grounded in reduced wildfire risk assumptions, regulatory validation of mitigation compliance, and an expectation of improving funds-from-operations to debt ratios.

02

Market read

Credit improvement plus regulatory cost recovery details can influence HE’s funding costs and risk premium, though equity impact may be secondary without new earnings or guidance.

03

What to watch

The article highlights cost recovery approval and mitigation spending, but does not quantify remaining exposure, claim outcomes beyond the pre-funded portion, or potential future regulatory changes.

Relevance 7/10Novelty 7/10Timing: post-upgrade credit action by S&P, ahead of next earnings for AI cues

Background

S&P’s action follows Hawaii Public Utilities Commission approval of about $350 million in cost recovery for HECO’s wildfire-mitigation plan investments over three years.

Company-level read

Ticker impact

$HEBullishMedium confidence
Context

S&P upgraded Hawaiian Electric Industries to BB- from B+ citing decreasing wildfire risk and a stable outlook across entities.

Expected impact

Likely modest positive bias for HE credit-sensitive trading, with limited upside unless equity investors reprice materially.

Evidence & confidence

The article is a ratings upgrade with specific regulatory approval and cash-flow/debt metrics, but it is not an earnings or equity guidance print.

Market effects

Supports the broader utility/regulated-asset narrative that wildfire mitigation and cost recovery can improve credit profiles.

Positive for Hawaii regulated utilities’ perceived risk, potentially easing local funding conditions.

Limited, mostly credit-market read-through for similarly exposed utilities.

Counterpoint

A ratings upgrade may not translate into equity rerating if wildfire claim liabilities or regulatory execution risk remain unresolved.

Key entities

  • Hawaiian Electric Industries Inc.

    S&P upgraded its rating to BB- from B+ and kept outlook stable, citing decreasing wildfire risks.

  • Hawaiian Electric Co. Inc. (HECO)

    HECO received affirmed BB rating on senior unsecured debt; recovery rating revised to 2 from 1.

  • Hawaii Public Utilities Commission

    Approved approximately $350 million in cost recovery for wildfire-mitigation plan investments on June 25, 2026.

  • S&P Global Ratings

    Issued the credit upgrade and maintained stable outlook across entities.

Related articles

$HEMed

HAWAIIAN ELECTRIC INDUSTRIES INC (HE): Results of Operations and Financial Condition

HAWAIIAN ELECTRIC INDUSTRIES INC (HE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 heiexhibit99-8xk08x07x26.htm EX-99 Document HEI Exhibit 99 NEWS RELEASE August 7, 2026 Contact: Mateo Garcia Telephone: (808) 543-7300 Director, Investor Relations E-mail: ir@hei.com HEI REPORTS SECOND QUARTER 2026 RESULTS • One of Hawaiian Electric’s Largest-Ever Energy

$UNHMed

COMMENTARY: Trump administration finds a new way to punish Medicare members — Hiking their drug bills

The article says the Trump administration, led by Medicare chief Mehmet Oz, will end the Part D Premium Stabilization Demonstration subsidy for Medicare drug coverage on Dec. 31 instead of continuing through at least 2027. It cites GAO cost estimates of about $9.8B over two years and warns premiums for 23M enrollees could rise, including possible doubling for 11M.

$CMIMed

Locally-made Cummins engine to hit market in 2027

Cummins said the EPA clarified emissions requirements, allowing its locally made X15N engine to move into market deployment. The EPA rule scales back emissions warranty requirements and removes deratement, with added lead time for useful-life rules. Cummins plans limited 2027 X15 and X10 production in Jan 2027, full production in Q4 2027 and Q3 2027. Cummins raised 2026 revenue guidance to up 10% to 13%.

$DEOMed

India warned Diageo that its whisky’s ’matured in American oak casks’ claim was misleading

Reuters reports India’s food regulator FSSAI warned Diageo’s unit United Spirits that its Royal Challenge whisky label claiming “matured in American oak casks” was misleading, saying most of the product was not matured. FSSAI also banned some Diageo and Inbrew brands for artificial flavouring. Diageo said it is engaging FSSAI and expects no financial impact.

$GEOMed

Reps. Lee, Deluzio, Dean demand overhaul at PA ICE detention facility

U.S. Reps. Madeleine Dean, Summer Lee and Chris Deluzio sent letters to GEO Group and ICE and DHS officials demanding reforms at the Moshannon Valley Processing Center, citing alleged medical staffing shortages, delayed medical screenings, and detainee deaths. They also raised concerns about ICE acting director David Venturella’s prior ties to GEO and asked for contract and compensation records within 14 days.

$GRALMed

GRAIL Announces FDA Advisory Committee Review Of Galleri Multi-Cancer Early Detection Test

GRAIL said the FDA Molecular and Clinical Genetics Panel will meet Sept. 23, 2026 to review its Premarket Approval application for Galleri, a multi-cancer early detection blood test. The submission cites PATHFINDER 2 (25,490 participants, one year) and NHS-Galleri (over 70,000). GRAIL says Galleri detects methylation patterns, with low false positives and accurate signal origin prediction.